With nearly $3.0B raised, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.

Life Sciences

Acquired by AstraZeneca in 2016
IPO in 2017 (NASDAQ: ANAB)
Acquired by Valeant Pharmaceuticals in 2014
Acquired by Allergan in 2016

Growth Buyout

Acquired by McKesson Corporation
Acquired by The Partners Group



Pharma Packager PCI Sells for More Than $1 Billion

Matrix Medical Network

Providence Service Corporation and Frazier Healthcare Partners Complete Formation of Strategic Partnership in Matrix Medical Network

Portola Pharmaceuticals

U.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients

Alpine Immune Sciences

Alpine Immune Sciences, Inc. Completes Merger with Nivalis Therapeutics, Inc.